FREE Case Review (866) 588-0600

Plaintiffs Respond to Defense’s Motion to Dismiss Risperdal Gynecomastia Lawsuits

Plaintiffs in Risperdal Gynecomastia Lawsuits currently pending in a mass tort litigation in Philadelphia have responded to a bid to have some of the complaints thrown out on grounds that the statute of limitations has expired.

Plaintiffs in Risperdal Gynecomastia Lawsuits currently pending in a mass tort litigation in Philadelphia have responded to a bid to have some of the complaints thrown out on grounds that the statute of limitations (SOL) has expired. Drugmaker Johnson & Johnson contends that the SOL governing Risperdal Lawsuits started on October 31, 2006, as plaintiffs began being warned about a potential link between Risperdal and male breast growth. However, in an answer filed with the Court on June 17, 2014, plaintiffs asserted that language added to Risperdal warning labels was not significantly different than earlier warnings, and that J&J did not engage in any meaningful effort to warn the public and medical communities about the risk of gynecomastia that has been linked to the drug.

Free Risperdal Lawsuit Evaluation: If you or a loved one developed gynecomastia after taking Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Risperdal and we can help.

What’s the Problem?

There are currently about 500 Risperdal lawsuits currently pending in Pennsylvania’s Philadelphia Court of Common Pleas. Most of the complaints allege that Risperdal can increase levels of prolactin, a hormone linked to lactation and female breast development. In adolescent boys and young men, elevated prolactin levels have been associated with abnormal breast tissue development. Among other things, J&J and its Janssen subsidiary have been accused of withholding information regarding side effects of the drug, including the link between Risperdal and gynecomastia. Plaintiffs further claim that J&J and Janssen improperly marketed Risperdal for “off-label” purposes, including to treat children long before pediatric uses were granted approval in 2006.

Risperdal Lawsuit Settlement

In November of 2013, J&J and Janssen agreed to pay $2.2 billion to settle allegations raised by the Justice Department over the marketing of Risperdal and other drugs. Among other things, the government charged the companies with improperly marketing Risperdal for pediatric use, and alleged that they had withheld information about the link between Risperdal and gynecomastia, in addition to other serious side effects.

Side Effects of Risperdal

  • Gynecomastia
  • Galactorrhea (production of milk from breasts)
  • Diabetes, high blood sugar (hyperglycemia)
  • Bone loss (demineralization)
  • Sexual dysfunction
  • Pituitary tumors
  • Tardive dyskinesia (involuntary movement disorder)
  • Weight gain
  • Neuroleptic Malignant Syndrome (NMS)
  • Heart problems, heart attack, irregular heart rhythm
  • Suicide
  • Pancreatitis
  • Cellulitis

Gynecomastia Treatment

  • Prescription medications – Tamoxifen and raloxifene are often prescribed for the treatment of gynecomastia. Although these drugs are approved to treat breast cancer, they are not officially indicated for the treatment of gynecomastia. Prescribing them in this capacity is done so ‘off-label’, and is done so at the physician’s discretion.
  • Surgery – If prescription medications are ineffective at treating gynecomastia, surgical intervention may be necessary. Surgery may include liposuction, where breast fat is removed, or a mastectomy, where the breast gland tissue is taken out.
  • Quitting Risperdal – If Risperdal has been determined to be the cause of gynecomastia, discontinuing treatment in favor of another drug with fewer potential side effects may be advised.

Can I File a Risperdal Gynecomastia Lawsuit?

Only a qualified attorney can determine whether you are eligible to file a Risperdal Lawsuit, which is why we are currently offering free case evaluations. Simply fill out the confidential evaluation form below to contact our law firm now.

Most cases involving pharmaceuticals allege that a product was sold with design, manufacturing, and/or marketing defects, which typically refers to a company’s failure to warn of a potential side effect. In the case of Risperdal, our attorneys suspect that patients may be able to take legal action in light of claims that manufacturers failed to adequately warn doctors and patients about the risk of gynecomastia.

How Can Filing a Lawsuit Help Me?

By filing a Risperdal Lawsuit, you may be entitled to collect compensation for all current and future medical expenses related to the treatment of your gynecomastia, as well as for damages for pain and suffering. Additionally, filing a lawsuit can help hold Risperdal’s manufacturer accountable for releasing an allegedly defective medication into the marketplace, and to discourage other pharmaceutical companies from engaging in similar conduct.

Do I have a Risperdal Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Risperdal lawsuits. We are handling individual litigation nationwide and currently accepting new Risperdal Gynecomastia cases in all 50 states.

Free Risperdal Lawsuit Evaluation: If you or a loved one was diagnosed with gynecomastia after taking Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a Risperdal Suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition